Nitric oxide and aids dementia

Dietmar Fuchs, Gabriele Baier-Bitterlich, Helmut Wachter, Stuart A. Lipton, Howard E. Gendelman

Research output: Contribution to journalLetter

5 Scopus citations

Abstract

To the Editor: Lipton and Gendelman ascribe a key role to macrophages and reactive oxygen intermediates in the pathogenesis of dementia associated with human immunodeficiency virus (HIV) infection (April 6 issue).1Since inhibi-tors of nitric oxide synthase were found to prevent gp120-induced neurotoxic effects in vitro, the authors speculate that nitric oxide triggers neurologic damage. However, it is questionable whether macrophages from humans, unlike those from other species, can produce relevant amounts of nitric oxide. Other cells in the brain, such as astrocytes, could be a source of nitric oxide, but there is no evidence of enhanced formation of nitric. . .

Original languageEnglish (US)
Pages (from-to)521-522
Number of pages2
JournalNew England Journal of Medicine
Volume333
Issue number8
DOIs
StatePublished - Aug 24 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Nitric oxide and aids dementia'. Together they form a unique fingerprint.

  • Cite this

    Fuchs, D., Baier-Bitterlich, G., Wachter, H., Lipton, S. A., & Gendelman, H. E. (1995). Nitric oxide and aids dementia. New England Journal of Medicine, 333(8), 521-522. https://doi.org/10.1056/NEJM199508243330814